In agreement with recent studies indicating a conserved role of IGF2BP1 in controlling cancer cell cycle progression by promoting E2F-driven gene expression (Müller et al., 2020), our studies identify cell cycle progression cancer hallmark gene sets as the most consistently deregulated pathways upon IGF2BP1 depletion. The gene discussed is IGF2BP1; the disease is cancer.